53 related articles for article (PubMed ID: 32615519)
1. ROS triggered cleavage of thioketal moiety to dissociate prodrug nanoparticles for chemotherapy.
Pan Q; Deng X; Gao W; Chang J; Pu Y; He B
Colloids Surf B Biointerfaces; 2020 Oct; 194():111223. PubMed ID: 32615519
[TBL] [Abstract][Full Text] [Related]
2. Chitosan oligosaccharide-functionalized nano-prodrug for cascade chemotherapy through oxidative stress amplification.
Cui L; Xu Q; Lou W; Wang Y; Xi X; Chen Y; Sun M; Wang Z; Zhang P; Yang S; Zhang L; Qu L
Int J Biol Macromol; 2024 May; 268(Pt 2):131641. PubMed ID: 38641277
[TBL] [Abstract][Full Text] [Related]
3. ROS-driven supramolecular nanoparticles exhibiting efficient drug delivery for chemo/Chemodynamic combination therapy for Cancer treatment.
Chen H; Xing C; Lei H; Yan B; Zhang H; Tong T; Guan Y; Kang Y; Pang J
J Control Release; 2024 Apr; 368():637-649. PubMed ID: 38484895
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-Loaded Physalis Mottle Virus Particles Function as a pH-Responsive Prodrug Enabling Cancer Therapy.
Hu H; Steinmetz NF
Biotechnol J; 2020 Dec; 15(12):e2000077. PubMed ID: 32918857
[TBL] [Abstract][Full Text] [Related]
5. A Novel Polyamino Acid Sulfur Dioxide Prodrug Synergistically Elevates ROS with β-Lapachone in Cancer Treatment.
Tang B; Zhang Y; Liu X; Wang Y; He P
J Pharm Sci; 2024 May; 113(5):1239-1247. PubMed ID: 38042342
[TBL] [Abstract][Full Text] [Related]
6. Polyprodrug nanomedicine for chemiexcitation-triggered self-augmented cancer chemotherapy and gas therapy.
Wang Q; Zhang C; Zhao Y; Jin Y; Zhou S; Qin J; Zhang W; Hu Y; Chen X; Yang K
Biomaterials; 2024 Sep; 309():122606. PubMed ID: 38776593
[TBL] [Abstract][Full Text] [Related]
7. Integration of caveolin-mediated cytosolic delivery and enzyme-responsive releasing of squalenoyl nanoparticles enhance the anti-cancer efficacy of chidamide in pancreatic cancer.
Chen J; Chen K; Xue S; Cheng X; Qi Y; Wang H; Li W; Cheng G; Xiong Y; Mu C; Gu M
Int J Pharm; 2024 Apr; 655():124072. PubMed ID: 38561133
[TBL] [Abstract][Full Text] [Related]
8. Polymeric Nanoparticles with ROS-Responsive Prodrug and Platinum Nanozyme for Enhanced Chemophotodynamic Therapy of Colon Cancer.
Hao Y; Chen Y; He X; Yu Y; Han R; Li Y; Yang C; Hu D; Qian Z
Adv Sci (Weinh); 2020 Oct; 7(20):2001853. PubMed ID: 33101874
[TBL] [Abstract][Full Text] [Related]
9. A Novel Cu(II) Loaded Polypeptide SO
Zhang Y; Zhang H; Wang Y; Ji Y; Wang F; He P
Macromol Biosci; 2024 Apr; 24(4):e2300429. PubMed ID: 37985928
[TBL] [Abstract][Full Text] [Related]
10. Pro-Nifuroxazide Self-Assembly Leads to Triggerable Nanomedicine for Anti-cancer Therapy.
Misra SK; Wu Z; Ostadhossein F; Ye M; Boateng K; Schulten K; Tajkhorshid E; Pan D
ACS Appl Mater Interfaces; 2019 May; 11(20):18074-18089. PubMed ID: 31013055
[TBL] [Abstract][Full Text] [Related]
11. Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfide bond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy.
Zhang H; Xu W; Omari-Siaw E; Liu Y; Chen B; Chen D; Yu J; Xu X
Drug Deliv; 2017 Nov; 24(1):1170-1178. PubMed ID: 28835137
[TBL] [Abstract][Full Text] [Related]
12. A pH-Sensitive Nanoparticle as Reactive Oxygen Species Amplifier to Regulate Tumor Microenvironment and Potentiate Tumor Radiotherapy.
Jiang X; Jiang X; Wu D; Xie W; Liu X; Zheng J
Int J Nanomedicine; 2024; 19():709-725. PubMed ID: 38283195
[TBL] [Abstract][Full Text] [Related]
13. Near-infrared light triggered activation of pro-drug combination cancer therapy and induction of immunogenic cell death.
Kang X; Cai Y; Wang Q; Wang C; Chen W; Yang W; Suryawanshi A; Zhou G; Chen P; Li F
Int J Pharm; 2021 Sep; 607():120972. PubMed ID: 34363916
[TBL] [Abstract][Full Text] [Related]
14. Coordinating bioorthogonal reactions with two tumor-microenvironment-responsive nanovehicles for spatiotemporally controlled prodrug activation.
Zuo L; Ding J; Li C; Lin F; Chen PR; Wang P; Lu G; Zhang J; Huang LL; Xie HY
Chem Sci; 2020 Jan; 11(8):2155-2160. PubMed ID: 34123305
[TBL] [Abstract][Full Text] [Related]
15. Tumor Microenvironment Cascade-Responsive Nanodrug with Self-Targeting Activation and ROS Regeneration for Synergistic Oxidation-Chemotherapy.
Li Y; Lin J; Wang P; Luo Q; Zhu F; Zhang Y; Hou Z; Liu X; Liu J
Nanomicro Lett; 2020 Sep; 12(1):182. PubMed ID: 34138172
[TBL] [Abstract][Full Text] [Related]
16. Cellular Trafficking of Sn-2 Phosphatidylcholine Prodrugs Studied with Fluorescence Lifetime Imaging and Super-resolution Microscopy.
Maji D; Lu J; Sarder P; Schmieder AH; Cui G; Yang X; Pan D; Lew MD; Achilefu S; Lanza GM
Precis Nanomed; 2018 Jul; 1(2):128-145. PubMed ID: 31249994
[TBL] [Abstract][Full Text] [Related]
17. Exploring hydrogen peroxide responsive thiazolidinone-based prodrugs.
Perez C; Monserrat JP; Chen Y; Cohen SM
Chem Commun (Camb); 2015 Apr; 51(33):7116-9. PubMed ID: 25811298
[TBL] [Abstract][Full Text] [Related]
18. Self-Triggered Apoptosis Enzyme Prodrug Therapy (STAEPT): Enhancing Targeted Therapies via Recurrent Bystander Killing Effect by Exploiting Caspase-Cleavable Linker.
Chung SW; Choi JU; Cho YS; Kim HR; Won TH; Dimitrion P; Jeon OC; Kim SW; Kim IS; Kim SY; Byun Y
Adv Sci (Weinh); 2018 Jul; 5(7):1800368. PubMed ID: 30027061
[TBL] [Abstract][Full Text] [Related]
19. Anticancer nano-prodrugs with drug release triggered by intracellular dissolution and hydrogen peroxide response.
Shibata A; Koseki Y; Tanita K; Kitajima S; Oka K; Maruoka K; Suzuki R; Thi Ngoc Dao A; Kasai H
Chem Commun (Camb); 2024 Jun; ():. PubMed ID: 38829169
[TBL] [Abstract][Full Text] [Related]
20. Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy.
Shen S; Yan Z; Wu J; Liu X; Guan G; Zou C; Guo Q; Zhu C; Liu T; Chen C; Chen L; Cheng P; Cheng W; Wu A
Front Oncol; 2020; 10():581197. PubMed ID: 33194713
[No Abstract] [Full Text] [Related]
[Next] [New Search]
